Compartir

Acceso a la atención médica Press Releases

14 de Enero de 2025

New Report Underscores Importance of RI Proposals Aiming to Limit Out-of-pocket Costs across Cancer Continuum

As Governor Daniel McKee prepares for his State of the State address, patient advocates are highlighting the results of a new report by the American Cancer Society Cancer Action Network (ACS CAN), which found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them. 

13 de Enero de 2025

New Report Underscores Importance of PA Proposal Limiting Out-of-pocket Costs for Diagnostic Tests for Breast Cancer

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

13 de Enero de 2025

New Report Underscores Importance of VA Proposal Limiting Out-of-pocket Costs for Diagnostic Tests for Breast Cancer

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

8 de Enero de 2025

Advocates Set Sights on Improving Access to Cancer Care, Reducing Burden of Disease for Maryland Patients in 2025

The following is a statement from American Cancer Society Cancer Action Network (ACS CAN) Maryland Government Relations Director Lance Kilpatrick:

“In 2024, Maryland state lawmakers heard from advocates across the disease spectrum and from every corner of the state, who united together to send a resounding message: improve access to lifesaving medication. Though the legislature did not advance the proposal to prohibit the use of copay accumulator adjustment programs, advocates are hopeful that lawmakers won’t miss the same opportunity in 2025.